A quality improvement initiative to reduce excess inhaled therapy use in the neonatal intensive care unit

Inhaled medications are commonly used at our single-center, Level IV neonatal intensive care unit (NICU). We lacked a standardized process for measuring efficacy of these medications to guide optimal duration of use, potentially leading to their overuse. We utilized quality improvement methodology t...

Full description

Saved in:
Bibliographic Details
Published inJournal of perinatology
Main Authors Zierk, Avery, Gumbel, Mary Jo, Mackenzie, Rachel, Matthews, Kelle, Simmons, Francis, Bustin, Anna, DeFelice, Christina, Morris, Heidi, Soorikian, Leane, Swartz, Kimberly, Nickel, Amanda, Gibbs, Kathleen
Format Journal Article
LanguageEnglish
Published United States 03.10.2024
Online AccessGet full text
ISSN0743-8346
1476-5543
1476-5543
DOI10.1038/s41372-024-02132-w

Cover

More Information
Summary:Inhaled medications are commonly used at our single-center, Level IV neonatal intensive care unit (NICU). We lacked a standardized process for measuring efficacy of these medications to guide optimal duration of use, potentially leading to their overuse. We utilized quality improvement methodology to reduce the length of inhaled hypertonic saline (HTS) course durations and high frequency albuterol use. Interventions included education, data sharing, and implementation of a respiratory therapy assessment tool. The average inhaled HTS course duration decreased from 8.7 to 4.2 days. The percentage of q4 albuterol administrations per total albuterol doses administered monthly decreased from 39 to 20%. Developing a shared mental model between interprofessional providers for the indication and effect of inhaled agents and standardizing assessment of these medications' efficacy can reduce their overuse.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0743-8346
1476-5543
1476-5543
DOI:10.1038/s41372-024-02132-w